Zimmer Biomet Q2 spine sales down 6.2% — 5 things to know

Zimmer Biomet reported a net sales decrease of 0.9 percent to $1.99 billion during the second quarter.

Advertisement

Five things to know:

1. Spine and craniomaxillofacial sales decreased 6.2 percent to $186 million compared to the same period last year.

2. Surgical, sports medicine, extremities and trauma sales increased 2.5 percent to $444 million.

3. Hip sales decreased 1.5 percent to $479 million and knee sales rose just 0.1 percent to $704 million.

4. Net earnings decreased 28.7 percent to $131.9 million for the same period last year.

5. Zimmer Biomet expects to hit its weighted average market growth rate six months ahead of schedule.

More articles on devices:
Johnson & Johnson, Stryker & more: How 8 companies are performing in spine
DJO, SeaSpine & more: 4 device company launches, releases
7 key updates on Globus Medical in 2019

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.